PreDxion Bio YC 지원서

Summer 2017Inactive

PreDxion Bio은(는) Summer 2017 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2017
산업: HealthcareDiagnostics
팀 규모: 6
상태: Inactive
출시됨: 2017

창업자

Walker McHughFounder
Timothy CornellFounder

PreDxion Bio의 사업 내용

PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.

PreDxion Bio의 YC 지원서, 재구성됨

Y Combinator 지원

PreDxion Bio, Summer 2017 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

PreDxion Bio

Describe what your company does in 50 characters or less.

Rapid, scalable diagnostic for SARS-CoV-2 and beyond

What is your company going to make? Please describe your product and what it does or will do.

We build a rapid antigen test that detects the SARS-CoV-2 spike protein from saliva, targeting asymptomatic and presymptomatic carriers. Our platform uses semiconductor fab processes allowing us to scale to tens of millions of tests in days. We originally started with sensors that monitor immune responses in critical care, now pivoting to large-scale infectious disease diagnostics.

Where do you live now, and where would the company be based after YC?

We are based in South San Francisco now and plan to remain here after YC, to stay close to biotech and semiconductor partners.

Explain your decision regarding location.

South San Francisco situates us amid biotech and diagnostics companies, and semiconductor fabs nearby for scaling manufacturing. It's critical for integrating our microfluidics and nanosensor technology with existing infrastructure.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

PreDxion Bio의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 PreDxion Bio의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. PreDxion Bio과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.